Population specific and up to date cardiovascular risk charts can be efficiently obtained with record linkage of routine and observational data.

BACKGROUND: Only few countries have cohorts enabling specific and up-to-date cardiovascular disease (CVD) risk estimation. Individual risk assessment based on study samples that differ too much from the target population could jeopardize the benefit of risk charts in general practice. Our aim was to provide up-to-date and valid CVD risk estimation for a Swiss population using a novel record linkage approach. METHODS: Anonymous record linkage was used to follow-up (for mortality, until 2008) 9,853 men and women aged 25-74 years who participated in the Swiss MONICA (MONItoring of trends and determinants in CVD) study of 1983-92. The linkage success was 97.8%, loss to follow-up 1990-2000 was 4.7%. Based on the ESC SCORE methodology (Weibull regression), we used age, sex, blood pressure, smoking, and cholesterol to generate three models. We compared the 1) original SCORE model with a 2) recalibrated and a 3) new model using the Brier score (BS) and cross-validation. RESULTS: Based on the cross-validated BS, the new model (BS = 14107×10(-6)) was somewhat more appropriate for risk estimation than the original (BS = 14190×10(-6)) and the recalibrated (BS = 14172×10(-6)) model. Particularly at younger age, derived absolute risks were consistently lower than those from the original and the recalibrated model which was mainly due to a smaller impact of total cholesterol. CONCLUSION: Using record linkage of observational and routine data is an efficient procedure to obtain valid and up-to-date CVD risk estimates for a specific population.

Derivation of traceable and transplantable photoreceptors from mouse embryonic stem cells.

Retinal degenerative diseases resulting in the loss of photoreceptors are one of the major causes of blindness. Photoreceptor replacement therapy is a promising treatment because the transplantation of retina-derived photoreceptors can be applied now to different murine retinopathies to restore visual function. To have an unlimited source of photoreceptors, we derived a transgenic embryonic stem cell (ESC) line in which the Crx-GFP transgene is expressed in photoreceptors and assessed the capacity of a 3D culture protocol to produce integration-competent photoreceptors. This culture system allows the production of a large number of photoreceptors recapitulating the in vivo development. After transplantation, integrated cells showed the typical morphology of mature rods bearing external segments and ribbon synapses. We conclude that a 3D protocol coupled with ESCs provides a safe and renewable source of photoreceptors displaying a development and transplantation competence comparable to photoreceptors from age-matched retinas.

The year in cardiology 2014: peripheral circulation.

In 2014, the debate on the indication of revascularization in case of asymptomatic carotid disease continued, while another one regarding the use of surgery vs. stenting addressed some new issues regarding the long-term cardiac risk of these patients. Renal arteries interventions trials were disappointing, as neither renal denervation nor renal artery stenting was found associated with better blood pressure management or outcome. In contrast, in lower-extremities artery disease, the endovascular techniques represent in 2014 major alternatives to surgery, even in distal arteries, with new insights regarding the interest of drug-eluting balloons. Regarding the aorta, the ESC published its first guidelines document on the entire vessel, emphasizing on the role of every cardiologist for screening abdominal aorta aneurysm during echocardiography. Among vascular wall biomarkers, the aorta stiffness is of increasing interest with new data and meta-analysis confirming its ability to stratify risk, whereas carotid intima-media thickness showed poor performances in terms of reclassifying patients into risk categories beyond risk scores. Regarding the veins, new data suggest the interest of D-dimers and residual venous thrombosis to help the decision of anti-coagulation prolongation or discontinuation after the initial period of treatment for deep vein thrombosis.

Low statin use in adults hospitalized with acute coronary syndrome.

OBJECTIVE: To assess recommended and actual use of statins in primary prevention of cardiovascular disease (CVD) based on clinical prediction scores in adults who develop their first acute coronary syndrome (ACS). METHOD: Cross-sectional study of 3172 adults without previous CVD hospitalized with ACS at 4 university centers in Switzerland. The number of participants eligible for statins before hospitalization was estimated based on the European Society of Cardiology (ESC) guidelines and compared to the observed number of participants on statins at hospital entry. RESULTS: Overall, 1171 (37%) participants were classified as high-risk (10-year risk of cardiovascular mortality ≥5% or diabetes); 1025 (32%) as intermediate risk (10-year risk <5% but ≥1%); and 976 (31%) as low risk (10-year risk <1%). Before hospitalization, 516 (16%) were on statins; among high-risk participants, only 236 of 1171 (20%) were on statins. If ESC primary prevention guidelines had been fully implemented, an additional 845 high-risk adults (27% of the whole sample) would have been eligible for statins before hospitalization. CONCLUSION: Although statins are recommended for primary prevention in high-risk adults, only one-fifth of them are on statins when hospitalized for a first ACS.

Cost evaluation and comparison of three decision strategies for cardiac revascularization : results of the suspected CAD protocol of the European CMR registry

Background: The public health burden of coronary artery disease (CAD) is important. Perfusion cardiac magnetic resonance (CMR) is generally accepted to detect and monitor CAD. Few studies have so far addressed its costs and costeffectiveness. Objectives: To compare in a large CMR registry the costs of a CMR-guided strategy vs two hypothetical invasive strategies for the diagnosis and the treatment of patients with suspected CAD. Methods: In 3'647 patients with suspected CAD included prospectively in the EuroCMR Registry (59 centers; 18 countries) costs were calculated for diagnostic examinations, revascularizations as well as for complication management over a 1-year follow-up. Patients with ischemia-positive CMR underwent an invasive X-ray coronary angiography (CXA) and revascularization at the discretion of the treating physician (=CMR+CXA strategy). Ischemia was found in 20.9% of patients and 17.4% of them were revascularized. In ischemia-negative patients by CMR, cardiac death and non-fatal myocardial infarctions occurred in 0.38%/y. In a hypothetical invasive arm the costs were calculated for an initial CXA followed by FFR testing in vessels with ≥50% diameter stenoses (=CXA+FFR strategy). To model this hypothetical arm, the same proportion of ischemic patients and outcome was assumed as for the CMR+CXA strategy. The coronary stenosis - FFR relationship reported in the literature was used to derive the proportion of patients with ≥50% diameter stenoses (Psten) in the study cohort. The costs of a CXA-only strategy were also calculated. Calculations were performed from a third payer perspective for the German, UK, Swiss, and US healthcare systems.

Etude de la composition initiale et du vieillissement des traces digitales: vers le développement d'une méthode de datation?

«Quel est l'âge de cette trace digitale?» Cette question est relativement souvent soulevée au tribunal ou lors d'investigations, lorsque la personne suspectée admet avoir laissé ses empreintes digitales sur une scène de crime mais prétend l'avoir fait à un autre moment que celui du crime et pour une raison innocente. Toutefois, aucune réponse ne peut actuellement être donnée à cette question, puisqu'aucune méthodologie n'est pour l'heure validée et acceptée par l'ensemble de la communauté forensique. Néanmoins, l'inventaire de cas américains conduit dans cette recherche a montré que les experts fournissent tout de même des témoignages au tribunal concernant l'âge de traces digitales, même si ceux-­‐ci sont majoritairement basés sur des paramètres subjectifs et mal documentés. Il a été relativement aisé d'accéder à des cas américains détaillés, ce qui explique le choix de l'exemple. Toutefois, la problématique de la datation des traces digitales est rencontrée dans le monde entier, et le manque de consensus actuel dans les réponses données souligne la nécessité d'effectuer des études sur le sujet. Le but de la présente recherche est donc d'évaluer la possibilité de développer une méthode de datation objective des traces digitales. Comme les questions entourant la mise au point d'une telle procédure ne sont pas nouvelles, différentes tentatives ont déjà été décrites dans la littérature. Cette recherche les a étudiées de manière critique, et souligne que la plupart des méthodologies reportées souffrent de limitations prévenant leur utilisation pratique. Néanmoins, certaines approches basées sur l'évolution dans le temps de composés intrinsèques aux résidus papillaires se sont montrées prometteuses. Ainsi, un recensement détaillé de la littérature a été conduit afin d'identifier les composés présents dans les traces digitales et les techniques analytiques capables de les détecter. Le choix a été fait de se concentrer sur les composés sébacés détectés par chromatographie gazeuse couplée à la spectrométrie de masse (GC/MS) ou par spectroscopie infrarouge à transformée de Fourier. Des analyses GC/MS ont été menées afin de caractériser la variabilité initiale de lipides cibles au sein des traces digitales d'un même donneur (intra-­‐variabilité) et entre les traces digitales de donneurs différents (inter-­‐variabilité). Ainsi, plusieurs molécules ont été identifiées et quantifiées pour la première fois dans les résidus papillaires. De plus, il a été déterminé que l'intra-­‐variabilité des résidus était significativement plus basse que l'inter-­‐variabilité, mais que ces deux types de variabilité pouvaient être réduits en utilisant différents pré-­‐ traitements statistiques s'inspirant du domaine du profilage de produits stupéfiants. Il a également été possible de proposer un modèle objectif de classification des donneurs permettant de les regrouper dans deux classes principales en se basant sur la composition initiale de leurs traces digitales. Ces classes correspondent à ce qui est actuellement appelé de manière relativement subjective des « bons » ou « mauvais » donneurs. Le potentiel d'un tel modèle est élevé dans le domaine de la recherche en traces digitales, puisqu'il permet de sélectionner des donneurs représentatifs selon les composés d'intérêt. En utilisant la GC/MS et la FTIR, une étude détaillée a été conduite sur les effets de différents facteurs d'influence sur la composition initiale et le vieillissement de molécules lipidiques au sein des traces digitales. Il a ainsi été déterminé que des modèles univariés et multivariés pouvaient être construits pour décrire le vieillissement des composés cibles (transformés en paramètres de vieillissement par pré-­‐traitement), mais que certains facteurs d'influence affectaient ces modèles plus sérieusement que d'autres. En effet, le donneur, le substrat et l'application de techniques de révélation semblent empêcher la construction de modèles reproductibles. Les autres facteurs testés (moment de déposition, pression, température et illumination) influencent également les résidus et leur vieillissement, mais des modèles combinant différentes valeurs de ces facteurs ont tout de même prouvé leur robustesse dans des situations bien définies. De plus, des traces digitales-­‐tests ont été analysées par GC/MS afin d'être datées en utilisant certains des modèles construits. Il s'est avéré que des estimations correctes étaient obtenues pour plus de 60 % des traces-­‐tests datées, et jusqu'à 100% lorsque les conditions de stockage étaient connues. Ces résultats sont intéressants mais il est impératif de conduire des recherches supplémentaires afin d'évaluer les possibilités d'application de ces modèles dans des cas réels. Dans une perspective plus fondamentale, une étude pilote a également été effectuée sur l'utilisation de la spectroscopie infrarouge combinée à l'imagerie chimique (FTIR-­‐CI) afin d'obtenir des informations quant à la composition et au vieillissement des traces digitales. Plus précisément, la capacité de cette technique à mettre en évidence le vieillissement et l'effet de certains facteurs d'influence sur de larges zones de traces digitales a été investiguée. Cette information a ensuite été comparée avec celle obtenue par les spectres FTIR simples. Il en a ainsi résulté que la FTIR-­‐CI était un outil puissant, mais que son utilisation dans l'étude des résidus papillaires à des buts forensiques avait des limites. En effet, dans cette recherche, cette technique n'a pas permis d'obtenir des informations supplémentaires par rapport aux spectres FTIR traditionnels et a également montré des désavantages majeurs, à savoir de longs temps d'analyse et de traitement, particulièrement lorsque de larges zones de traces digitales doivent être couvertes. Finalement, les résultats obtenus dans ce travail ont permis la proposition et discussion d'une approche pragmatique afin d'aborder les questions de datation des traces digitales. Cette approche permet ainsi d'identifier quel type d'information le scientifique serait capable d'apporter aux enquêteurs et/ou au tribunal à l'heure actuelle. De plus, le canevas proposé décrit également les différentes étapes itératives de développement qui devraient être suivies par la recherche afin de parvenir à la validation d'une méthodologie de datation des traces digitales objective, dont les capacités et limites sont connues et documentées. -- "How old is this fingermark?" This question is relatively often raised in trials when suspects admit that they have left their fingermarks on a crime scene but allege that the contact occurred at a time different to that of the crime and for legitimate reasons. However, no answer can be given to this question so far, because no fingermark dating methodology has been validated and accepted by the whole forensic community. Nevertheless, the review of past American cases highlighted that experts actually gave/give testimonies in courts about the age of fingermarks, even if mostly based on subjective and badly documented parameters. It was relatively easy to access fully described American cases, thus explaining the origin of the given examples. However, fingermark dating issues are encountered worldwide, and the lack of consensus among the given answers highlights the necessity to conduct research on the subject. The present work thus aims at studying the possibility to develop an objective fingermark dating method. As the questions surrounding the development of dating procedures are not new, different attempts were already described in the literature. This research proposes a critical review of these attempts and highlights that most of the reported methodologies still suffer from limitations preventing their use in actual practice. Nevertheless, some approaches based on the evolution of intrinsic compounds detected in fingermark residue over time appear to be promising. Thus, an exhaustive review of the literature was conducted in order to identify the compounds available in the fingermark residue and the analytical techniques capable of analysing them. It was chosen to concentrate on sebaceous compounds analysed using gas chromatography coupled with mass spectrometry (GC/MS) or Fourier transform infrared spectroscopy (FTIR). GC/MS analyses were conducted in order to characterize the initial variability of target lipids among fresh fingermarks of the same donor (intra-­‐variability) and between fingermarks of different donors (inter-­‐variability). As a result, many molecules were identified and quantified for the first time in fingermark residue. Furthermore, it was determined that the intra-­‐variability of the fingermark residue was significantly lower than the inter-­‐variability, but that it was possible to reduce both kind of variability using different statistical pre-­‐ treatments inspired from the drug profiling area. It was also possible to propose an objective donor classification model allowing the grouping of donors in two main classes based on their initial lipid composition. These classes correspond to what is relatively subjectively called "good" or "bad" donors. The potential of such a model is high for the fingermark research field, as it allows the selection of representative donors based on compounds of interest. Using GC/MS and FTIR, an in-­‐depth study of the effects of different influence factors on the initial composition and aging of target lipid molecules found in fingermark residue was conducted. It was determined that univariate and multivariate models could be build to describe the aging of target compounds (transformed in aging parameters through pre-­‐ processing techniques), but that some influence factors were affecting these models more than others. In fact, the donor, the substrate and the application of enhancement techniques seemed to hinder the construction of reproducible models. The other tested factors (deposition moment, pressure, temperature and illumination) also affected the residue and their aging, but models combining different values of these factors still proved to be robust. Furthermore, test-­‐fingermarks were analysed with GC/MS in order to be dated using some of the generated models. It turned out that correct estimations were obtained for 60% of the dated test-­‐fingermarks and until 100% when the storage conditions were known. These results are interesting but further research should be conducted to evaluate if these models could be used in uncontrolled casework conditions. In a more fundamental perspective, a pilot study was also conducted on the use of infrared spectroscopy combined with chemical imaging in order to gain information about the fingermark composition and aging. More precisely, its ability to highlight influence factors and aging effects over large areas of fingermarks was investigated. This information was then compared with that given by individual FTIR spectra. It was concluded that while FTIR-­‐ CI is a powerful tool, its use to study natural fingermark residue for forensic purposes has to be carefully considered. In fact, in this study, this technique does not yield more information on residue distribution than traditional FTIR spectra and also suffers from major drawbacks, such as long analysis and processing time, particularly when large fingermark areas need to be covered. Finally, the results obtained in this research allowed the proposition and discussion of a formal and pragmatic framework to approach the fingermark dating questions. It allows identifying which type of information the scientist would be able to bring so far to investigators and/or Justice. Furthermore, this proposed framework also describes the different iterative development steps that the research should follow in order to achieve the validation of an objective fingermark dating methodology, whose capacities and limits are well known and properly documented.

Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.

OBJECTIVE: To evaluate the population and economic impact of implementing the new Joint National Committee (JNC) or European Society of Hypertension (ESH)/European Society of Cardiology (ESC) hypertension guidelines in the Swiss population. METHODS: Cross-sectional, population-based sample (6708 participants) collected between 2003 and 2006 in the city of Lausanne, Switzerland. Blood pressure categories were defined according to both the JNC (JNC-7 and JNC-8) and the ESH/ESC (2007 and 2013) guidelines. RESULTS: The proportion of participants aged 35-60 years eligible for drug treatment was 25.6% [95% confidence interval (CI) 24.4-26.9%] and 24.8% (95% CI 23.6-26.0%) for the JNC-7 and the JNC-8 guidelines, respectively; for participants aged 60-75 years, the values were 62.3% (95% CI 60.1-64.5%) and 46.8% (95% CI 44.5-49.0%), respectively. Shifting from the JNC-7 to the JNC-8 guidelines would lead to an annual saving of 163.6 million Swiss francs (187.7 million US dollars or 134.5 million European euro). The proportion of participants aged 35-75 years without chronic kidney disease, diabetes mellitus or reported history of cardiovascular disease and eligible for treatment was 30.2% (95% CI 29.0-31.4%) for the ESH/ESC 2007 and 2013 guidelines. For participants with chronic kidney disease, diabetes mellitus or reported history of cardiovascular disease, the values were 73.6% (95% CI 70.8-76.3%) and 55.6% (95% CI 52.5-58.8%), respectively. Shifting from the ESH/ESC 2007 to the ESH/ESC 2013 guidelines would lead to an annual saving of 86.9 million Swiss francs (99.5 million US dollars or 71.4 million European euro). CONCLUSION: In Switzerland, shifting from the JNC-7 to the JNC-8 guidelines or from the ESH/ESC 2007 to the ESH/ESC 2013 guidelines would decrease the prevalence of patients eligible for treatment and increase the percentage of treated patients within blood pressure goals. Both strategies lead to potential savings in antihypertensive drug treatment.